Carregant...
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises. Several vaccine approaches and repurposed drugs are currently under evaluation for safety and efficacy. However, none of them have been approved for COVID-19 yet. Meanwhile, several nMAbs targeting SARS-CoV-2 spike g...
Guardat en:
| Publicat a: | Biomed J |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Chang Gung University
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685954/ https://ncbi.nlm.nih.gov/pubmed/33589377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bj.2020.11.011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|